GBA1 rs121908759: What Your Genotype Means
The rs121908759 variant in the GBA1 gene is a well-studied genetic change known as p.Leu483Pro (historically referred to as L444P). It is recognized as a pathogenic variant that determines carrier status for Gaucher disease and serves as a significant genetic risk factor for developing Parkinson disease.
What each genotype means
Typical GBA1 activity
This genotype represents the common, non-variant form of the GBA1 gene. Individuals with this profile do not carry the specific L444P (p.Leu483Pro) mutation associated with Gaucher disease or increased Parkinson's disease risk.
This is the most common genotype found in the general population across all ancestries.
Increased Parkinson's disease risk
This genotype indicates you are a carrier of the pathogenic L444P (p.Leu483Pro) variant. Research shows that heterozygous carriers have a significantly increased risk of developing Parkinson's disease compared to non-carriers, and this variant is also associated with Gaucher disease carrier status. Please discuss any health concerns or symptoms with your clinician, as this variant is considered one of the stronger genetic risk factors for Parkinson's.
Carried by a small percentage of the population, with a global allele frequency of approximately 0.0016 in gnomAD data.
Gaucher disease risk
This genotype indicates you carry two copies of the pathogenic L444P (p.Leu483Pro) variant. Biallelic pathogenic variants in GBA1 are the cause of Gaucher disease, a lysosomal storage disorder. You should consult with a medical geneticist or specialist to discuss the clinical implications of this finding.
This genotype is very rare in the general population.
Understanding the rs121908759 Variant
The rs121908759 variant is a specific change in the DNA sequence of the GBA1 gene. In scientific literature, this variant is frequently identified by its protein-level change, p.Leu483Pro, though it is widely known in legacy medical texts as L444P. This variant is classified as a missense mutation, meaning it results in the substitution of one amino acid for another within the protein structure. Because GBA1 is a critical gene, such changes can alter the function of the resulting enzyme. Researchers track this specific SNP to understand how it influences the risk of certain lysosomal storage disorders and neurodegenerative conditions. It is considered a 'severe' variant in the context of clinical genetics, as it is strongly linked to more pronounced health outcomes when inherited in specific patterns.
The Role of the GBA1 Gene
The GBA1 gene provides instructions for producing an enzyme called glucocerebrosidase. This enzyme is primarily located in lysosomes, which are the recycling centers of cells. Its main job is to break down a fatty substance called glucocerebroside into simpler components, such as glucose and ceramide. When the GBA1 gene contains pathogenic variants like rs121908759, the resulting enzyme may have reduced activity or stability. This can lead to the accumulation of fatty substances within cells, which is the hallmark of Gaucher disease. Beyond this, the dysfunction of this enzyme is increasingly recognized as a major contributor to the development of Parkinson disease. The exact biological mechanisms linking enzyme deficiency to the aggregation of proteins like alpha-synuclein in the brain remain a subject of active, ongoing research.
Research and Clinical Associations
The evidence linking rs121908759 to clinical outcomes is robust. In its biallelic form (where both copies of the gene are affected), this variant is associated with Gaucher disease, a lysosomal storage disorder. However, even in a heterozygous state (carrying one copy), this variant is an established risk factor for Parkinson disease. Studies indicate that carriers of 'severe' variants like rs121908759 face a higher risk of developing Parkinson disease compared to the general population, often with an earlier age of onset. While the association is strong, it is important to note that penetrance is incomplete; not every carrier will develop Parkinson disease. The risk is influenced by a complex interplay of genetic background, environmental factors, and other modifiers. Current research continues to refine these risk estimates to better understand why some individuals remain unaffected.
Population Frequency
The rs121908759 variant is found across various global populations, though its prevalence varies by ancestry. It is notably common in certain Asian and Hispanic lineages, where it is often cited as a frequent pathogenic variant. In contrast, other variants like p.N370S are more common in Ashkenazi Jewish populations. According to data from the Genome Aggregation Database (gnomAD), the global allele frequency is approximately 0.0016. Because this variant is relatively widespread, it is a common focus in genetic screening studies for neurodegenerative risk. Understanding its frequency helps researchers contextualize the burden of GBA1-related disease across different ethnic groups and informs the development of targeted clinical screening programs.
Interpreting Your Genetic Information
If you have information regarding your GBA1 status, it is essential to interpret it within the context of your overall health and family history. Carrying this variant does not mean you will develop a disease; rather, it indicates a statistically higher susceptibility to certain conditions. This information is for educational purposes and should never be used to self-diagnose or make medical decisions. If you are concerned about your risk for Parkinson disease or Gaucher disease, the most appropriate step is to consult with a board-certified genetic counselor or a neurologist. They can provide personalized context, discuss the implications of your specific genotype, and help you understand the current landscape of clinical monitoring and research. Always discuss any health concerns or potential medication adjustments with your primary healthcare provider.
How common is this variant?
The rs121908759 variant has a global allele frequency of approximately 0.0016, with higher prevalence observed across various Asian and Hispanic lineages.
Frequently asked questions
Does having the GBA1 rs121908759 variant mean I will get Parkinson disease?
No, carrying this variant does not guarantee that you will develop Parkinson disease. It is considered a risk factor, meaning it increases the statistical likelihood, but many carriers never develop the condition.
What is the difference between Gaucher disease and Parkinson disease in relation to GBA1?
Gaucher disease is a rare lysosomal storage disorder typically caused by having two copies of a pathogenic GBA1 variant. Parkinson disease is a neurodegenerative condition that has been linked to having one or more GBA1 variants as a risk factor.
Should I get tested for GBA1 variants?
Genetic testing for GBA1 is typically reserved for individuals with a family history of Gaucher disease or Parkinson disease, or those showing specific clinical symptoms. You should discuss the necessity and implications of such testing with a genetic counselor or your doctor.
Is there a cure for GBA1-associated Parkinson disease?
Currently, there is no cure for GBA1-associated Parkinson disease, and treatment focuses on managing symptoms. Research into gene-targeted therapies and enzyme replacement is ongoing, but these are not standard clinical treatments for Parkinson disease at this time.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908759?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GBA1
Also known as the N370S (p.Asn409Ser) mutation, this missense variant is a classic cause of Gaucher disease type 1 in homozygotes and significantly elevates Parkinson's disease risk in heterozygotes.
A variant in the GBA1 gene associated with Gaucher disease and increased risk for Parkinson's disease.
Pathogenic missense substitution (p.Leu483Pro / L444P) in GBA1 associated with Gaucher disease.
Pathogenic missense substitution (p.Asn409Ser) conferring carrier status for Gaucher disease type 1.
Pathogenic variant (c.84dupG) causing severe deficiency in glucocerebrosidase activity, associated with Gaucher disease.
A pathogenic variant (p.Asn409Ser, formerly N370S) in GBA1 associated with Gaucher disease and increased risk for Parkinson disease.